Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody engineering.

L G Presta1

  • 1Department of Protein Engineering, Genentech Inc, South San Francisco, California 94080.

Current Opinion in Biotechnology
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Antibody engineering advances focus on creating constructs with scientific and medical value. Recent successes include humanizing non-human antibodies and utilizing phage display for antibody development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering therapeutic antibodies for improved function.

Biochemical Society transactions·2002
Same author

Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule.

Science (New York, N.Y.)·2002
Same author

Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: a candidate therapeutic for IDDM and SLE.

Cytokine·2001
Same author

Engineered antibodies with increased activity to recruit complement.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

The Journal of biological chemistry·2000
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Biotechnology
  • Immunology
  • Structural Biology

Background:

  • Antibody engineering is crucial for developing therapeutics with both scientific and medical applications.
  • Recent advancements have focused on improving antibody efficacy and specificity.

Purpose of the Study:

  • To review significant developments in antibody engineering over the past year.
  • To highlight key techniques such as antibody humanization and phage display.

Main Methods:

  • Review of current literature and research in antibody engineering.
  • Analysis of successful antibody humanization strategies.
  • Examination of phage display applications in antibody development.

Main Results:

Related Experiment Videos

  • Successful humanization of non-human antibodies, retaining binding specificity.
  • Effective application of phage display for antibody selection and engineering.
  • Demonstrated progress in designing antibodies for therapeutic and diagnostic purposes.

    • Conclusions:

    • Antibody engineering continues to yield significant scientific and medical breakthroughs.
    • Humanization and phage display are powerful tools for creating clinically relevant antibodies.
    • The field shows strong potential for future therapeutic innovations.